TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $99.0M in total; no superinvestor holds it.
Other share classesTLSIW
Q4 2024 vs. Q3 2024
How the institutions holding TriSalus Life Sciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 2.17M | 2.35M | +174.5K (+8.0%) |
| Value | $10.0M | $11.8M | +$1.74M (+17.4%) |
New holders (3)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 27,989 | $140.2K | 0.16% |
| Renaissance Technologies LLC | 13,400 | $67.1K | 0.00% |
| Advisor Group Holdings, Inc. | 79 | $395 | 0.00% |
Sold out (6)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Virtu Financial LLC | 19,875 | $92.0K |
| HRT Financial LP | 15,575 | $71.0K |
| Walleye Capital LLC | 14,376 | $66.3K |
| Magnetar Financial LLC | 14,232 | $65.6K |
| Two Sigma Securities, LLC | 10,192 | $47.0K |
| Morgan Stanley | 1,135 | $5.23K |